![Aberrant Expression of SATB2, CDX2, CDH17 and CK20 in Hepatocellular Carcinoma: Pathologic, Clinical and Outcome Study - Kmeid - - Histopathology - Wiley Online Library Aberrant Expression of SATB2, CDX2, CDH17 and CK20 in Hepatocellular Carcinoma: Pathologic, Clinical and Outcome Study - Kmeid - - Histopathology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/d8f6ff0f-6862-4a77-b32a-87f270ea418a/his14420-toc-0001-m.jpg)
Aberrant Expression of SATB2, CDX2, CDH17 and CK20 in Hepatocellular Carcinoma: Pathologic, Clinical and Outcome Study - Kmeid - - Histopathology - Wiley Online Library
![Cellular prognostic markers in hepatitis-related hepatocellular carcinoma | Infectious Agents and Cancer | Full Text Cellular prognostic markers in hepatitis-related hepatocellular carcinoma | Infectious Agents and Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13027-018-0183-8/MediaObjects/13027_2018_183_Fig1_HTML.gif)
Cellular prognostic markers in hepatitis-related hepatocellular carcinoma | Infectious Agents and Cancer | Full Text
PLOS ONE: Identification of Serum Monocyte Chemoattractant Protein-1 and Prolactin as Potential Tumor Markers in Hepatocellular Carcinoma
![Molecular classification of hepatocellular carcinoma: potential therapeutic implications | Hepatic Oncology Molecular classification of hepatocellular carcinoma: potential therapeutic implications | Hepatic Oncology](https://www.futuremedicine.com/cms/10.2217/hep.15.26/asset/images/medium/figure1.gif)
Molecular classification of hepatocellular carcinoma: potential therapeutic implications | Hepatic Oncology
![Therapeutic efficacy of a Dioscorea membranacea extract in a rat model of hepatocellular carcinoma: Histopathological aspects - ScienceDirect Therapeutic efficacy of a Dioscorea membranacea extract in a rat model of hepatocellular carcinoma: Histopathological aspects - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2225411021000109-fx1.jpg)
Therapeutic efficacy of a Dioscorea membranacea extract in a rat model of hepatocellular carcinoma: Histopathological aspects - ScienceDirect
![Immunohistochemical Analysis of Hepatocellular and Adenocarcinoma in the Liver: MOC31 Compares Favorably with Other Putative Markers | Modern Pathology Immunohistochemical Analysis of Hepatocellular and Adenocarcinoma in the Liver: MOC31 Compares Favorably with Other Putative Markers | Modern Pathology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fmodpathol.3880134/MediaObjects/41379_2000_Article_BF3880134_Fig1_HTML.jpg)
Immunohistochemical Analysis of Hepatocellular and Adenocarcinoma in the Liver: MOC31 Compares Favorably with Other Putative Markers | Modern Pathology
![Spontaneous development of hepatocellular carcinoma with cancer stem cell properties in PR‐SET7‐deficient livers | The EMBO Journal Spontaneous development of hepatocellular carcinoma with cancer stem cell properties in PR‐SET7‐deficient livers | The EMBO Journal](https://www.embopress.org/cms/asset/b8bdf218-4344-46af-8175-ceafd2520f54/embj201489279-fig-0006-m.jpg)
Spontaneous development of hepatocellular carcinoma with cancer stem cell properties in PR‐SET7‐deficient livers | The EMBO Journal
![GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma - Journal of Hepatology GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma - Journal of Hepatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2000733266/2001950994/gr1.jpg)
GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma - Journal of Hepatology
![Serum anti-EIF3A autoantibody as a potential diagnostic marker for hepatocellular carcinoma.,Scientific Reports - X-MOL Serum anti-EIF3A autoantibody as a potential diagnostic marker for hepatocellular carcinoma.,Scientific Reports - X-MOL](https://xpic.x-mol.com/20190730%2F10.1038_s41598-019-47365-4.jpg)
Serum anti-EIF3A autoantibody as a potential diagnostic marker for hepatocellular carcinoma.,Scientific Reports - X-MOL
![Hepatocellular carcinoma treated with sorafenib: Arterial tumor perfusion in dynamic contrast-enhanced CT as early imaging biomarkers for survival - European Journal of Radiology Hepatocellular carcinoma treated with sorafenib: Arterial tumor perfusion in dynamic contrast-enhanced CT as early imaging biomarkers for survival - European Journal of Radiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2119039813/2088394288/gr1.jpg)